Cargando…

Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?

SIMPLE SUMMARY: Chronic pain is being increasingly recognized and addressed in small animal practice. The recent recognition that inability to communicate does not negate the possibility to experience pain requires veterinarians to actively recognize, assess and manage animal pain. In order to succe...

Descripción completa

Detalles Bibliográficos
Autores principales:	della Rocca, Giorgia, Gamba, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065429/ https://www.ncbi.nlm.nih.gov/pubmed/33805489 http://dx.doi.org/10.3390/ani11040952

Ejemplares similares

Palmitoylethanolamide and Related ALIAmides for Small Animal Health: State of the Art
por: della Rocca, Giorgia, et al.
Publicado: (2022)

Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy
por: Kongara, Kavitha, et al.
Publicado: (2018)

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double‐blind, multicentre, randomized, placebo‐controlled study
por: Noli, Chiara, et al.
Publicado: (2019)

Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function
por: Alshelh, Zeynab, et al.
Publicado: (2019)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
por: Seol, Tai-Kyung, et al.
Publicado: (2017)

Dietary Strategies for Relieving Stress in Pet Dogs and Cats
por: Fan, Zhicong, et al.
Publicado: (2023)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
por: D’Amico, Ramona, et al.
Publicado: (2020)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019)

Orofacial Pain Management: An Overview of the Potential Benefits of Palmitoylethanolamide and Other Natural Agents
por: Santonocito, Simona, et al.
Publicado: (2023)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders
por: Assogna, Martina, et al.
Publicado: (2022)

Combination of Rehabilitative Therapy with Ultramicronized Palmitoylethanolamide for Chronic Low Back Pain: An Observational Study
por: Scaturro, Dalila, et al.
Publicado: (2019)

Looking for Responders among Women with Chronic Pelvic Pain Treated with a Comicronized Formulation of Micronized Palmitoylethanolamide and Polydatin
por: Indraccolo, Ugo, et al.
Publicado: (2022)

Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
por: Lang-Illievich, Kordula, et al.
Publicado: (2023)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

Palmitoyl-glucosamine co-micronized with curcumin for maintenance of meloxicam-induced pain relief in dogs with osteoarthritis pain
por: della Rocca, Giorgia, et al.
Publicado: (2023)

Palmitoylethanolamide: A Natural Compound for Health Management
por: Clayton, Paul, et al.
Publicado: (2021)

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
por: Cocito, Dario, et al.
Publicado: (2014)

Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
por: Schifilliti, Chiara, et al.
Publicado: (2014)

Initial Psychometric Testing and Validation of the Italian Version of the Canine Brief Pain Inventory in Dogs With Pain Related to Osteoarthritis
por: della Rocca, Giorgia, et al.
Publicado: (2021)

Dietary Patterns and Interventions to Alleviate Chronic Pain
por: Dragan, Simona, et al.
Publicado: (2020)

Pain and Problem Behavior in Cats and Dogs
por: Mills, Daniel S., et al.
Publicado: (2020)

Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential
por: Nestmann, Earle R.
Publicado: (2016)

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
por: Valenza, Marta, et al.
Publicado: (2022)

Comment on “Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain”
por: Kriek, R.
Publicado: (2014)

Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
por: Passavanti, Maria Beatrice, et al.
Publicado: (2019)

Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection
por: Hesselink, J M Keppel
Publicado: (2013)

Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
por: Keppel Hesselink, Jan M, et al.
Publicado: (2015)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease
por: De Santis, Francesca, et al.
Publicado: (2022)

Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats
por: Domínguez-Oliva, Adriana, et al.
Publicado: (2021)

The place of oxycodone/naloxone in chronic pain management
por: Leppert, Wojciech
Publicado: (2013)

Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence
por: Scuteri, Damiana, et al.
Publicado: (2022)

Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats
por: Enomoto, Masataka, et al.
Publicado: (2019)

Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells
por: Keppel Hesselink, Jan M, et al.
Publicado: (2013)

Anaesthesia for the geriatric dog and cat
por: Hughes, JML
Publicado: (2008)

Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome
por: Cervigni, M., et al.
Publicado: (2019)

Dietary Interventions for Treatment of Chronic Pain: Oxidative Stress and Inflammation
por: Kaushik, Ashish S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n8svp8gghukvefe9o6svof5qer